How many acquisitions has Telix Pharma made so far?

Telix Pharma has completed 9 acquisitions so far, with an average acquisition amount of $63M.

Which countries does Telix Pharma usually acquire in?

Telix Pharma has made acquisitions in 6 countries with the most activity in United States and France.

Which is Telix Pharma's latest acquisition?

Telix Pharma's most recent acquisition is RLS, a Developer of molecular imaging products and services, acquired in September 2024.

Which sectors does Telix Pharma target for acquisitions?

Most of Telix Pharma's acquisitions are in Biopharma Outsourcing (3) and Immunotherapy (3).

In which year did Telix Pharma make the most acquisitions?

Telix Pharma was most active in 2024, with 4 acquisitions completed in that year.

List of 9 Acquisitions by Telix Pharma (Aug 2026)

Telix Pharma has made a total of 9 acquisitions. The peak years for these transactions were 2024 with 4, 2018 with 2, and 2023 with 1. Operations span 6 countries, including United States, France, and Canada, across 5 sectors, such as Oncology, Biopharma Outsourcing, and Immunotherapy. The average number of acquisitions from 2020 to 2025 is 1.2, with 0 acquisitions completed this calendar year. Its most recent acquisition, RLS, is a Miami-based developer of molecular imaging products and services founded in 2018 and acquired in September 2024.

Here's the year on year acquisition history of Telix Pharma:

Number of Total Acquisitions

Year	# Acquisitions
2024	4
2023	1
2022	1
2020	1
2018	2

View all Acquisitions by Telix Pharma

Recent acquisitions by Telix Pharma

Telix Pharma's most recent acquisition - RLS is a Developer of molecular imaging products and services, founded in 2018 and located in Miami. Telix Pharma acquired it in September 2024 for a price of $*****.

Here is the list of all acquisitions by Telix Pharma sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Sep 23, 2024	RLS	xfeq	gzij	81	112
Mar 05, 2024	ARTMS	mawz	bipy	93	669
Feb 27, 2024	IsoTherapeutics Group	dmsl	cqzm	89	187
Feb 08, 2024	QSAM Biosciences	raxe	qrlx	98	729
Apr 27, 2023	Dedicaid	bqcf	uexi	49	818